News Image

Daxor's Blood Volume Analysis Uncovers Hidden Heart Failure Subtype in Nearly 1 in 5 Patients, Enabling Targeted Treatment

Provided By GlobeNewswire

Last update: Feb 14, 2025

Case Reports in the Journal of the American College of Cardiology Underscore the Critical Role of Blood Volume Analysis in Optimizing Heart Failure Treatment

Read more at globenewswire.com

DAXOR CORP

NASDAQ:DXR (12/4/2025, 11:23:38 AM)

13.02

+0.37 (+2.92%)



Find more stocks in the Stock Screener

Follow ChartMill for more